Isoflavones have been shown in animal models and in vitro studies to protect against NAFLD via multiple mechanisms that modulate oxidative stress, lipid synthesis, fatty acid β-oxidation, peroxisome proliferator-activated receptor α (PPARα) activity, and aldose reductase/polyol production (42). Here, AKR1B1 is linked to metabolic dysfunction-associated steatotic liver disease.